FM Nirmala Sitharaman meets top WTO official amid push for vax IPR waiver

The meeting between Sitharaman and Iweala took place on the sidelines of the World Bank and IMF annual meetings

Nirmala Sitharaman
The meeting assumes significance as India along with South Africa has been pushing for a temporary waiver of intellectual property rights on Covid-19 vaccines and medicines globally. (Photo: Twitter/@FinMinIndia)
Press Trust of India Washington
2 min read Last Updated : Oct 16 2021 | 1:01 AM IST

Finance Minister Nirmala Sitharaman on Friday met the Director General of WTO Ngozi Okonjo Iweala here in the US amidst India's proposal for a temporary waiver of intellectual property rights on COVID-19 vaccines and medicines worldwide.

The meeting between Sitharaman and Iweala took place on the sidelines of the World Bank and IMF annual meetings.

Union Finance Minister Smt. @nsitharaman interacts with Dr. Ngozi Okonjo Iweala @NOIweala, Director General @WTO on the sidelines of @WorldBank-@IMFNews Annual Meetings 2021 in Washington D.C., today, the Ministry of Finance said on Twitter.

The meeting assumes significance as India along with South Africa has been pushing for a temporary waiver of intellectual property rights on COVID-19 vaccines and medicines globally.

India in June suggested to the World Trade Organisation (WTO) members to begin text-based negotiations on the temporary TRIPs waiver proposal to deal with the COVID-19 pandemic.

In October 2020, India and South Africa had submitted the first proposal, suggesting a waiver for all WTO members on the implementation of certain provisions of the TRIPs Agreement in relation to the prevention, containment or treatment of COVID-19.

In May this year, a revised proposal was submitted by 62 co-sponsors, including India, South Africa and Indonesia.

The agreement on Trade-Related Aspects of Intellectual Property Rights or TRIPs came into effect in January 1995. It is a multilateral agreement on Intellectual Property (IP) rights such as copyright, industrial designs, patents and protection of undisclosed information or trade secrets.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Nirmala SitharamanWTOCoronavirus VaccineIMF-World Bank MeetIPR

First Published: Oct 16 2021 | 1:01 AM IST

Next Story